Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma

被引：0
|
作者：
Hewen Shi
Ying Zou
Xiaoxue Wang
Guoli Wang
Yijia Gao
Fan Yi
junqing Xu
Yancun Yin
Defang Li
Minjing Li
机构：
[1] Binzhou Medical University,Featured Laboratory for Biosynthesis and Target Discovery of Active Components of Traditional Chinese Medicine, School of Integrated Traditional Chinese and Western Medicine
[2] Binzhou Medical University,School of Basic Medical Sciences
[3] Qingdao University Medical College,Department of Hematology
[4] Affiliated Yantai Yuhuangding Hoepital,undefined
来源：
Discover Oncology | / 14卷
关键词：
Hippo pathway; Nevadensin; YAP; Sensitization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Activating the Hippo pathway by nevadensin overcomes Yap-drived resistance to sorafenib in hepatocellular carcinoma
    Shi, Hewen
    Zou, Ying
    Wang, Xiaoxue
    Wang, Guoli
    Gao, Yijia
    Yi, Fan
    Xu, Junqing
    Yin, Yancun
    Li, Defang
    Li, Minjing
    DISCOVER ONCOLOGY, 2023, 14 (01)
  • [2] Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
    Y-C Shen
    D-L Ou
    C Hsu
    K-L Lin
    C-Y Chang
    C-Y Lin
    S-H Liu
    A-L Cheng
    British Journal of Cancer, 2013, 108 : 72 - 81
  • [3] Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinoma
    Shen, Y-C
    Ou, D-L
    Hsu, C.
    Lin, K-L
    Chang, C-Y
    Lin, C-Y
    Liu, S-H
    Cheng, A-L
    BRITISH JOURNAL OF CANCER, 2013, 108 (01) : 72 - 81
  • [4] SETD1A augments sorafenib primary resistance via activating YAP in hepatocellular carcinoma
    Wu, Jugang
    Chai, Hongjuan
    Li, Feng
    Ren, Qing
    Gu, Yan
    LIFE SCIENCES, 2020, 260
  • [5] CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
    Zibo Chen
    Tao Yuan
    Fangjie Yan
    Song Ye
    Qin Xie
    Bo Zhang
    Nengmin Lin
    Qiaojun He
    Bo Yang
    Hong Zhu
    BMC Cancer, 22
  • [6] CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death
    Ding, Bisha
    Bao, Chang
    Jin, Luqi
    Xu, Liang
    Fan, Weimin
    Lou, Weiyang
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [7] CT-707 overcomes hypoxia-mediated sorafenib resistance in Hepatocellular carcinoma by inhibiting YAP signaling
    Chen, Zibo
    Yuan, Tao
    Yan, Fangjie
    Ye, Song
    Xie, Qin
    Zhang, Bo
    Lin, Nengmin
    He, Qiaojun
    Yang, Bo
    Zhu, Hong
    BMC CANCER, 2022, 22 (01)
  • [8] YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin
    Ting Sun
    Wenhao Mao
    Hui Peng
    Qi Wang
    Lin Jiao
    Cellular Oncology, 2021, 44 : 689 - 699
  • [9] YAP promotes sorafenib resistance in hepatocellular carcinoma by upregulating survivin
    Sun, Ting
    Mao, Wenhao
    Peng, Hui
    Wang, Qi
    Jiao, Lin
    CELLULAR ONCOLOGY, 2021, 44 (03) : 689 - 699
  • [10] Regulation of stemness by Hippo-YAP pathway under hypoxia in hepatocellular carcinoma
    Kim, Ji Su
    Ahn, Ei Yong
    Park, Young Nyun
    CANCER RESEARCH, 2013, 73
12345